HROW
HARROW, INC.
Company overview
- Market capitalization
- $1.18B
- Employees
- 373
- Latest publication
- 2026-09-29
About HARROW, INC.
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; BYOOVIZ, a LUCENTIS biosimilar indicated for the treatment of patients with Neovascular (Wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV); VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; OPUVIZ, an EYLEA biosimilar indicated for the treatment of patients with Wet AMD, macular edema following RVO, diabetic macular edema (DME), and diabetic retinopathy (DR); MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44,203,000USD | 89,092,000USD | 71,638,000USD | 63,742,000USD | 47,831,000USD | 66,831,000USD | 49,257,000USD | 48,939,000USD |
| Cost Of Revenue | 17,158,000USD | 18,468,000USD | 17,712,000USD | 16,230,000USD | 15,524,000USD | 14,135,000USD | 12,018,000USD | 12,539,000USD |
| Gross Profit | 27,045,000USD | 70,624,000USD | 53,926,000USD | 47,512,000USD | 32,307,000USD | 52,696,000USD | 37,239,000USD | 36,400,000USD |
| Research Development | 5,895,000USD | 3,273,000USD | 3,323,000USD | 2,868,000USD | 3,026,000USD | 4,755,000USD | 2,273,000USD | 3,053,000USD |
| Selling General Administrative | 43,230,000USD | 43,310,000USD | 35,856,000USD | 33,235,000USD | 40,513,000USD | 34,789,000USD | 33,645,000USD | 31,817,000USD |
| Total Operating Expenses | 49,125,000USD | 46,583,000USD | 39,179,000USD | 36,103,000USD | 43,539,000USD | 39,797,000USD | 35,918,000USD | 34,870,000USD |
| Operating Income | -22,080,000USD | 24,041,000USD | 14,747,000USD | 11,409,000USD | -11,232,000USD | 12,899,000USD | 1,321,000USD | 1,530,000USD |
| Interest Expense | 5,497,000USD | 5,186,000USD | 6,038,000USD | 6,408,000USD | 6,548,000USD | 6,375,000USD | 5,525,000USD | 5,471,000USD |
| Net Interest Income | -5,497,000USD | -5,186,000USD | -6,038,000USD | -6,408,000USD | -6,548,000USD | -6,375,000USD | -5,525,000USD | -5,471,000USD |
| Income Before Tax | -27,577,000USD | 10,397,000USD | 1,020,000USD | 4,995,000USD | -17,780,000USD | 6,263,000USD | -4,200,000USD | -5,818,000USD |
| Income Tax Expense | 25,000USD | 3,771,000USD | — | — | — | -514,000USD | 20,000USD | 655,000USD |
| Tax Provision | 25,000USD | 3,771,000USD | 0USD | 0USD | — | -514,000USD | 20,000USD | 655,000USD |
| Net Income | -27,602,000USD | 6,626,000USD | 1,020,000USD | 4,995,000USD | -17,780,000USD | 6,777,000USD | -4,220,000USD | -6,473,000USD |
| Net Income From Continuing Ops | -27,602,000USD | 6,626,000USD | 1,020,000USD | 4,995,000USD | -17,780,000USD | 6,777,000USD | -4,220,000USD | -6,473,000USD |
| Ebit | -22,080,000USD | 24,041,000USD | 7,058,000USD | 11,409,000USD | -11,232,000USD | 13,152,000USD | 1,321,000USD | 1,530,000USD |
| Ebitda | -16,496,000USD | 28,820,000USD | 11,624,000USD | 15,982,000USD | -6,694,000USD | 17,548,000USD | 4,277,000USD | 4,380,000USD |
| Depreciation And Amortization | 5,584,000USD | 4,779,000USD | 4,566,000USD | 4,573,000USD | 4,538,000USD | 4,396,000USD | 2,956,000USD | 2,850,000USD |
| Reconciled Depreciation | 5,776,000USD | 4,967,000USD | 4,898,000USD | 4,904,000USD | 4,908,000USD | 4,811,000USD | 3,346,000USD | 3,200,000USD |
| Total Other Income Expense Net | -5,497,000USD | -13,644,000USD | -13,727,000USD | -6,414,000USD | -6,548,000USD | -6,636,000USD | -5,521,000USD | -7,348,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 272,303,000USD | 199,614,000USD | 130,193,000USD | 88,595,000USD | 72,476,000USD | 48,871,000USD | 51,165,000USD | 41,372,000USD |
| Cost Of Revenue | 67,934,000USD | 49,245,000USD | 39,640,000USD | 25,383,000USD | 18,214,000USD | 14,463,000USD | 16,749,000USD | 16,521,000USD |
| Gross Profit | 204,369,000USD | 150,369,000USD | 90,553,000USD | 63,212,000USD | 54,262,000USD | 34,408,000USD | 34,416,000USD | 24,851,000USD |
| Research Development | 12,846,000USD | 12,230,000USD | 6,652,000USD | 3,050,000USD | 11,084,000USD | 2,413,000USD | 2,083,000USD | 825,000USD |
| Selling General Administrative | 152,914,000USD | 129,064,000USD | 83,090,000USD | 58,243,000USD | 41,315,000USD | 31,247USD | 33,096,000USD | 29,243,000USD |
| Total Operating Expenses | 165,760,000USD | 141,547,000USD | 90,122,000USD | 61,293,000USD | 52,648,000USD | 34,023,000USD | 39,211,000USD | 30,068,000USD |
| Operating Income | 38,609,000USD | 8,822,000USD | 431,000USD | 1,919,000USD | 1,614,000USD | 385,000USD | -4,795,000USD | -5,217,000USD |
| Interest Expense | 24,180,000USD | 22,786,000USD | 21,324,000USD | 7,244,000USD | 5,436,000USD | 2,236,000USD | 2,500,000USD | 2,728,000USD |
| Net Interest Income | -24,180,000USD | -22,786,000USD | -21,324,000USD | -7,244,000USD | -5,436,000USD | -2,236,000USD | -2,500,000USD | -2,728,000USD |
| Income Before Tax | -1,724,000USD | -17,320,000USD | -23,710,000USD | -14,011,000USD | -17,874,000USD | -3,415,000USD | -117,000USD | 14,625,000USD |
| Income Tax Expense | 3,415,000USD | 161,000USD | 701,000USD | 75,000USD | 133,000USD | 4,000USD | 8,000USD | -19,449,000USD |
| Tax Provision | 3,771,000USD | 161,000USD | 701,000USD | 75,000USD | 133,000USD | 4,000USD | 0USD | 0USD |
| Net Income | -5,139,000USD | -17,481,000USD | -24,411,000USD | -14,086,000USD | -18,007,000USD | -3,357,000USD | 168,000USD | 14,625,000USD |
| Net Income From Continuing Ops | -5,139,000USD | -17,481,000USD | -24,411,000USD | -14,086,000USD | -18,007,000USD | -3,419,000USD | -125,000USD | 14,625,000USD |
| Ebit | 38,609,000USD | 9,075,000USD | 811,000USD | 1,919,000USD | 3,363,000USD | 748,000USD | -755,000USD | -5,217,000USD |
| Ebitda | 57,515,000USD | 22,127,000USD | 11,948,000USD | 4,750,000USD | 5,104,000USD | 2,617,000USD | 1,908,000USD | -3,374,000USD |
| Depreciation And Amortization | 18,906,000USD | 13,052,000USD | 11,137,000USD | 2,831,000USD | 1,741,000USD | 1,869,000USD | 2,663,000USD | 1,843,000USD |
| Reconciled Depreciation | 19,677,000USD | 14,537,000USD | 12,340,000USD | 3,665,000USD | 2,396,000USD | 2,743,000USD | 2,663,000USD | 1,843,000USD |
| Total Other Income Expense Net | -40,333,000USD | -26,142,000USD | -24,141,000USD | -15,930,000USD | -19,488,000USD | -3,800,000USD | 4,678,000USD | 19,842,000USD |
| Non Operating Income Net Other | — | — | — | -8,686,000USD | -14,052,000USD | -73,000USD | 7,178,000USD | 22,570,000USD |
| Net Income Applicable To Common Shares | — | — | — | -14,086,000USD | -18,479,000USD | -3,357,000USD | 168,000USD | 14,625,000USD |
| Minority Interest | — | — | — | — | 8,000USD | -62,000USD | 293,000USD | -293,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 31,215,753USD | — | — |
| Unclassified Operating Expenses | — | — | — | — | — | — | 4,032,000USD | — |
| Interest Income | — | — | — | — | — | — | 4,048,000USD | 20,132,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 419,543,000USD | 399,482,000USD | 363,074,000USD | 345,033,000USD | 364,164,000USD | 388,971,000USD | 351,539,000USD | 306,630,000USD |
| Intangible Assets | 182,106,000USD | 175,174,000USD | 173,787,000USD | 178,144,000USD | 182,392,000USD | 186,700,000USD | 191,141,000USD | 156,850,000USD |
| Other Current Assets | 13,985,000USD | 27,928,000USD | 12,652,000USD | 8,702,000USD | 14,802,000USD | 15,101,000USD | 10,343,000USD | 6,781,000USD |
| Total Liab | 391,192,000USD | 347,391,000USD | 316,413,000USD | 295,734,000USD | 308,068,000USD | 319,674,000USD | 293,918,000USD | 248,453,000USD |
| Total Stockholder Equity | 28,706,000USD | 52,446,000USD | 47,016,000USD | 49,654,000USD | 56,451,000USD | 69,652,000USD | 57,976,000USD | 58,532,000USD |
| Other Current Liab | 64,399,000USD | 60,060,000USD | 45,203,000USD | 41,068,000USD | 40,822,000USD | 52,040,000USD | 69,084,000USD | 32,359,000USD |
| Common Stock | 37,000USD | 37,000USD | 37,000USD | 36,000USD | 35,000USD | 35,000USD | 35,000USD | 35,000USD |
| Capital Stock | 37,000USD | 37,000USD | 37,000USD | 36,000USD | 35,000USD | 35,000USD | 35,000USD | 35,000USD |
| Retained Earnings | -184,126,000USD | -156,524,000USD | -163,150,000USD | -164,170,000USD | -169,165,000USD | -151,385,000USD | -158,162,000USD | -153,942,000USD |
| Good Will | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD |
| Cash | 94,644,000USD | 72,927,000USD | 74,290,000USD | 52,963,000USD | 66,726,000USD | 47,247,000USD | 72,601,000USD | 70,968,000USD |
| Cash And Short Term Investments | 94,644,000USD | 72,927,000USD | 74,290,000USD | 55,814,000USD | 66,726,000USD | 47,247,000USD | 72,601,000USD | 70,968,000USD |
| Total Current Assets | 226,384,000USD | 211,750,000USD | 177,604,000USD | 154,890,000USD | 169,535,000USD | 189,651,000USD | 147,062,000USD | 139,390,000USD |
| Total Current Liabilities | 91,439,000USD | 96,302,000USD | 65,400,000USD | 248,884,000USD | 186,986,000USD | 91,343,000USD | 95,005,000USD | 53,551,000USD |
| Net Debt | 206,024,000USD | 179,049,000USD | 177,582,000USD | 178,288,000USD | 163,280,000USD | 181,581,000USD | 123,463,000USD | 121,365,000USD |
| Short Term Debt | 915,000USD | 887,000USD | 859,000USD | 184,401,000USD | 108,924,000USD | 497,000USD | 507,000USD | 767,000USD |
| Short Long Term Debt Total | 300,668,000USD | 251,976,000USD | 251,872,000USD | 231,251,000USD | 230,006,000USD | 228,828,000USD | 196,064,000USD | 192,333,000USD |
| Long Term Debt | 292,087,000USD | 243,184,000USD | 242,874,000USD | 38,484,000USD | 112,501,000USD | 219,539,000USD | 186,057,000USD | 185,023,000USD |
| Net Receivables | 101,259,000USD | 110,895,000USD | 77,828,000USD | 78,822,000USD | 77,291,000USD | 116,601,000USD | 53,962,000USD | 52,216,000USD |
| Inventory | 16,495,999USD | 13,523,000USD | 12,834,000USD | 11,552,000USD | 10,716,000USD | 10,702,000USD | 10,156,000USD | 9,425,000USD |
| Accounts Payable | 26,125,000USD | 35,355,000USD | 18,993,000USD | 23,415,000USD | 37,095,000USD | 38,762,000USD | 25,277,000USD | 20,177,000USD |
| Property Plant Equipment Net | 10,721,000USD | 11,043,000USD | 11,351,000USD | 11,667,000USD | 11,905,000USD | 12,288,000USD | 13,004,000USD | 10,058,000USD |
| Property Plant Equipment Gross | 10,721,000USD | 23,267,000USD | 23,350,000USD | 23,325,000USD | 23,231,000USD | 23,302,000USD | 24,024,000USD | 20,727,000USD |
| Common Stock Shares Outstanding | 37,231,321shares | 36,760,461shares | 38,875,005shares | 38,853,855shares | 35,826,000shares | 35,808,000shares | 35,702,000shares | 35,619,000shares |
| Non Current Assets Total | 193,159,000USD | 187,732,000USD | 185,470,000USD | 190,143,000USD | 194,629,000USD | 199,320,000USD | 204,477,000USD | 167,240,000USD |
| Non Current Liabilities Total | 299,753,000USD | 251,089,000USD | 251,013,000USD | 46,850,000USD | 121,082,000USD | 228,331,000USD | 198,913,000USD | 194,902,000USD |
| Non Currrent Assets Other | 11,773,000USD | 1,183,000USD | 1,330,000USD | 1,478,000USD | — | 12,288,000USD | 1,869,000USD | -1,966,001USD |
| Net Working Capital | 134,945,000USD | 115,448,000USD | 112,204,000USD | -93,994,000USD | -17,451,000USD | 98,308,000USD | 52,057,000USD | 85,839,000USD |
| Unclassified Non Current Assets | -11,773,000USD | — | — | — | — | -12,288,000USD | — | — |
| Unclassified Non Current Liabilities | 7,666,000USD | 7,905,000USD | 8,139,000USD | 8,366,000USD | 8,581,000USD | 8,792,000USD | 12,856,000USD | 9,879,000USD |
| Unclassified Equity | 212,758,000USD | 208,896,000USD | 210,092,000USD | 213,752,000USD | 225,546,000USD | 220,967,000USD | 216,068,000USD | 212,858,000USD |
| Unclassified Current Assets | — | -13,523,000USD | — | — | -3,457,000USD | -3,410,000USD | — | -1,453,000USD |
| Current Deferred Revenue | — | — | 345,000USD | 91,000USD | 145,000USD | 44,000USD | 137,000USD | 248,000USD |
| Short Long Term Debt | — | — | — | 183,619,000USD | 108,313,000USD | — | — | — |
| Short Term Investments | — | — | — | 2,851,000USD | 3,457,000USD | 3,410,000USD | 1,450,000USD | 1,453,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | — | — | — | -454,000USD |
| Unclassified Current Liabilities | — | — | — | -183,710,000USD | -108,313,000USD | — | — | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 399,482,000USD | 388,971,000USD | 311,755,000USD | 157,023,000USD | 98,329,000USD | 57,474,000USD | 59,085,000USD | 49,451,000USD |
| Intangible Assets | 175,174,000USD | 186,700,000USD | 159,906,000USD | 25,837,000USD | 17,126,000USD | 2,524,000USD | 2,337,000USD | 3,059,000USD |
| Other Current Assets | 14,405,000USD | 15,101,000USD | 8,951,000USD | 21,990,000USD | 1,257,000USD | 1,612,000USD | 1,508,000USD | 912,000USD |
| Total Liab | 347,391,000USD | 319,674,000USD | 241,753,000USD | 130,138,000USD | 87,398,000USD | 30,646,000USD | 31,667,000USD | 24,700,000USD |
| Total Stockholder Equity | 52,446,000USD | 69,652,000USD | 70,357,000USD | 26,885,000USD | 11,286,000USD | 27,183,000USD | 27,711,000USD | 24,751,000USD |
| Other Current Liab | 59,272,000USD | 52,040,000USD | 27,114,000USD | -836,000USD | 4,252,000USD | 2,668,000USD | 2,410,000USD | 2,847,000USD |
| Common Stock | 37,000USD | 35,000USD | 35,000USD | 30,000USD | 27,000USD | 26,000USD | 26,000USD | 24,000USD |
| Capital Stock | 37,000USD | 35,000USD | 35,000USD | 30,000USD | 27,000USD | 26,000USD | 26,000USD | 24,000USD |
| Retained Earnings | -156,524,000USD | -151,385,000USD | -133,904,000USD | -109,493,000USD | -95,407,000USD | -77,400,000USD | -74,043,000USD | -74,211,000USD |
| Good Will | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 332,000USD | 2,227,000USD |
| Cash | 72,927,000USD | 47,247,000USD | 74,085,000USD | 96,270,000USD | 42,167,000USD | 4,101,000USD | 4,749,000USD | 6,638,000USD |
| Cash And Short Term Investments | 72,927,000USD | 47,247,000USD | 82,766,000USD | 96,270,000USD | 50,670,000USD | 32,746,000USD | 29,949,000USD | 28,058,000USD |
| Total Current Assets | 211,750,000USD | 189,651,000USD | 139,073,000USD | 118,260,000USD | 60,662,000USD | 40,982,000USD | 36,767,000USD | 32,843,000USD |
| Total Current Liabilities | 96,302,000USD | 91,343,000USD | 49,344,000USD | 18,632,000USD | 9,722,000USD | 10,799,000USD | 12,284,000USD | 11,901,000USD |
| Current Deferred Revenue | 788,000USD | 44,000USD | 75,000USD | 113,000USD | 16,000USD | 66,000USD | 57,000USD | 119,000USD |
| Net Debt | 179,049,000USD | 181,581,000USD | 116,417,000USD | 7,904,000USD | 35,789,000USD | 19,432,000USD | 16,242,000USD | 8,610,000USD |
| Short Term Debt | 887,000USD | 497,000USD | 806,000USD | 723,000USD | 280,000USD | 4,486,000USD | 2,408,000USD | 3,969,000USD |
| Short Long Term Debt Total | 251,976,000USD | 228,828,000USD | 190,502,000USD | 104,897,000USD | 77,956,000USD | 23,533,000USD | 20,991,000USD | 15,248,000USD |
| Long Term Debt | 243,184,000USD | 219,539,000USD | 183,172,000USD | 104,174,000USD | 71,654,000USD | 12,378,000USD | 12,219,000USD | 11,999,000USD |
| Net Receivables | 110,895,000USD | 116,601,000USD | 36,489,000USD | 6,388,000USD | 4,518,000USD | 2,662,000USD | 2,009,000USD | 1,964,000USD |
| Inventory | 13,523,000USD | 10,702,000USD | 10,867,000USD | 6,541,000USD | 4,217,000USD | 3,962,000USD | 3,301,000USD | 1,834,000USD |
| Accounts Payable | 35,355,000USD | 38,762,000USD | 21,424,000USD | 18,632,000USD | 5,174,000USD | 3,645,000USD | 7,409,000USD | 4,966,000USD |
| Property Plant Equipment Net | 11,043,000USD | 12,288,000USD | 12,444,000USD | 10,999,000USD | 9,076,000USD | 10,667,000USD | 11,934,000USD | 6,375,000USD |
| Property Plant Equipment Gross | 23,267,000USD | 23,302,000USD | 20,378,000USD | 20,060,000USD | 16,909,000USD | 11,252,000USD | 11,934,000USD | 6,375,000USD |
| Common Stock Shares Outstanding | 36,760,461shares | 35,650,714shares | 32,616,777shares | 27,460,968shares | 26,757,000shares | 25,895,000shares | 26,466,000shares | 23,812,000shares |
| Non Current Assets Total | 187,732,000USD | 199,320,000USD | 172,682,000USD | 37,168,000USD | 37,667,000USD | 16,492,000USD | 22,318,000USD | 16,608,000USD |
| Non Current Liabilities Total | 251,089,000USD | 228,331,000USD | 192,409,000USD | 111,506,000USD | 77,676,000USD | 19,847,000USD | 19,383,000USD | 12,799,000USD |
| Non Currrent Assets Other | 1,183,000USD | 14,038,987,712,000USD | -2,138,000USD | 1,950,000USD | 12,446,000USD | 3,820,000USD | 7,715,000USD | 4,947,000USD |
| Net Working Capital | 115,448,000USD | 98,308,000USD | 90,138,000USD | 99,628,000USD | 50,940,000USD | 29,332,000USD | 24,483,000USD | 20,942,000USD |
| Unclassified Non Current Liabilities | 7,905,000USD | 8,792,000USD | 9,237,000USD | -1,950,000USD | — | — | — | — |
| Unclassified Equity | 208,896,000USD | 220,967,000USD | 204,600,000USD | 136,318,000USD | 106,639,000USD | 104,531,000USD | 101,702,000USD | 103,278,000USD |
| Other Assets | — | 199,319,800,680,000USD | — | 1,595,000USD | — | 10,619USD | — | — |
| Short Term Investments | — | 3,410,000USD | 8,681,000USD | 5,589,000USD | 8,503,000USD | 28,645,000USD | 25,200,000USD | 21,420,000USD |
| Unclassified Current Assets | — | -3,410,000USD | — | -18,518,000USD | — | — | — | — |
| Unclassified Non Current Assets | — | -213,358,788,392,000USD | — | -3,545,000USD | -12,446,000USD | -4,681,619USD | -7,715,000USD | -4,947,000USD |
| Accumulated Other Comprehensive Income | — | — | -409,000USD | — | — | — | 0USD | -4,364,000USD |
| Deferred Long Term Liab | — | — | — | 1,950,000USD | — | — | — | — |
| Long Term Investments | — | — | — | 0USD | 11,133,000USD | 3,820,000USD | 7,715,000USD | 4,947,000USD |
| Non Current Liabilities Other | — | — | — | 7,332,000USD | 6,022,000USD | 7,469,000USD | 7,164,000USD | 800,000USD |
| Net Tangible Assets | — | — | — | 1,426,000USD | -6,172,000USD | 24,912,000USD | 25,042,000USD | 19,465,000USD |
| Other Liab | — | — | — | — | — | 800,000USD | 800,000USD | 800,000USD |
| Short Long Term Debt | — | — | — | — | — | 3,898,000USD | 1,772,000USD | 2,529,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -3,964,000USD | -1,772,000USD | -2,529,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -27,602,000USD | 6,626,000USD | 1,020,000USD | 4,995,000USD | -17,780,000USD | 6,777,000USD | -4,220,000USD | -6,473,000USD |
| Depreciation | 5,584,000USD | 4,967,000USD | 4,898,000USD | 6,193,000USD | 4,908,000USD | 4,811,000USD | 3,744,000USD | 3,200,000USD |
| Stock Based Compensation | 3,837,000USD | 3,800,000USD | 3,271,000USD | 875,000USD | 4,556,000USD | 4,794,000USD | 4,385,000USD | 4,271,000USD |
| Other Non Cash Items | 448,000USD | 4,649,000USD | 9,086,000USD | -12,741,000USD | 1,389,000USD | 970,000USD | 3,693,000USD | 2,887,000USD |
| Change To Account Receivables | 9,831,000USD | -33,215,000USD | 1,014,000USD | -1,985,000USD | 39,196,000USD | -62,779,000USD | -1,822,000USD | -24,027,000USD |
| Change To Inventory | -2,973,000USD | -689,000USD | -1,282,000USD | -836,000USD | -14,000USD | -546,000USD | -731,000USD | 1,385,000USD |
| Change In Working Capital | 8,741,000USD | -11,631,000USD | -1,687,000USD | -125,000USD | 26,595,000USD | -35,131,000USD | -4,651,000USD | -7,254,000USD |
| Total Cash From Operating Activities | -8,992,000USD | 8,411,000USD | 16,588,000USD | -803,000USD | 19,668,000USD | -17,779,000USD | 2,951,000USD | -2,746,000USD |
| Capital Expenditures | -194,000USD | -341,000USD | -210,000USD | -166,000USD | -212,000USD | -37,560,000USD | -604,000USD | -344,000USD |
| Free Cash Flow | -9,186,000USD | 8,070,000USD | 16,378,000USD | -969,000USD | 19,456,000USD | -55,339,000USD | 2,347,000USD | -3,090,000USD |
| Total Cashflows From Investing Activities | -18,203,000USD | -4,730,000USD | -225,000USD | -293,000USD | -212,000USD | -37,560,000USD | -597,000USD | 5,103,000USD |
| Net Borrowings | 49,000,000USD | -2,000USD | — | — | 0USD | 29,780,000USD | 0USD | — |
| Total Cash From Financing Activities | 48,912,000USD | -5,044,000USD | 4,964,000USD | -12,667,000USD | 23,000USD | 29,985,000USD | -721,000USD | 73,000USD |
| Change In Cash | 21,717,000USD | -1,363,000USD | 21,327,000USD | -13,763,000USD | 19,479,000USD | -25,354,000USD | 1,633,000USD | 2,430,000USD |
| Begin Period Cash Flow | 72,927,000USD | 74,290,000USD | 52,963,000USD | 66,726,000USD | 47,247,000USD | 72,601,000USD | 70,968,000USD | 68,538,000USD |
| End Period Cash Flow | 94,644,000USD | 72,927,000USD | 74,290,000USD | 52,963,000USD | 66,726,000USD | 47,247,000USD | 72,601,000USD | 70,968,000USD |
| Other Cashflows From Investing Activities | -18,203,000USD | 134,000USD | -15,000USD | -127,000USD | -42,000USD | -37,005,000USD | 7,000USD | 5,447,000USD |
| Other Cashflows From Financing Activities | 48,912,000USD | -5,176,000USD | -7,091,000USD | 102,000USD | 23,000USD | 205,000USD | 484,000USD | -100,000USD |
| Unclassified Financing Cash Flow | -49,000,000USD | — | 12,055,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | -4,523,000USD | — | — | — | 74,565,000USD | — | -5,103,000USD |
| Investments | — | — | -225,000USD | -293,000USD | -212,000USD | -37,560,000USD | -597,000USD | 5,103,000USD |
| Sale Purchase Of Stock | — | — | — | -12,769,000USD | — | — | -1,205,000USD | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,139,000USD | -17,481,000USD | -24,411,000USD | -14,086,000USD | -18,007,000USD | -3,419,000USD | -125,000USD | 14,625,000USD |
| Depreciation | 19,677,000USD | 14,537,000USD | 12,340,000USD | 3,665,000USD | 2,396,000USD | 2,743,000USD | 2,663,000USD | 1,843,000USD |
| Stock Based Compensation | 12,502,000USD | 17,619,000USD | 15,696,000USD | 7,974,000USD | 5,745,000USD | 2,775,000USD | 2,023,000USD | 2,636,000USD |
| Other Non Cash Items | 16,639,000USD | 7,749,000USD | 7,350,000USD | 9,720,000USD | 677,000USD | 3,070,000USD | 512,000USD | 613,000USD |
| Change To Account Receivables | 5,010,000USD | -80,232,000USD | -30,344,000USD | -1,860,000USD | -1,831,000USD | -866,000USD | -95,000USD | -384,000USD |
| Change To Inventory | -2,821,000USD | 165,000USD | -4,326,000USD | -2,324,000USD | -255,000USD | -661,000USD | -2,271,000USD | 415,000USD |
| Change In Working Capital | 185,000USD | -44,626,000USD | -7,135,000USD | -5,568,000USD | -253,000USD | -6,269,000USD | -1,723,000USD | 3,437,000USD |
| Total Cash From Operating Activities | 43,864,000USD | -22,202,000USD | 3,840,000USD | 1,705,000USD | 5,082,000USD | -1,100,000USD | 950,000USD | 687,000USD |
| Capital Expenditures | -887,000USD | -38,674,000USD | -152,553,000USD | -7,773,000USD | -28,512,000USD | -994,000USD | -1,837,000USD | -2,203,000USD |
| Free Cash Flow | 42,977,000USD | -60,876,000USD | -148,713,000USD | -6,068,000USD | -23,430,000USD | -2,094,000USD | -887,000USD | -1,516,000USD |
| Investments | 0USD | -33,164,000USD | -152,553,000USD | -1,743,000USD | -2,766,000USD | -981,000USD | -1,833,000USD | 4,000USD |
| Total Cashflows From Investing Activities | -5,460,000USD | -33,164,000USD | -152,553,000USD | -1,743,000USD | -18,686,000USD | -981,000USD | -1,833,000USD | -2,199,000USD |
| Net Borrowings | 13,472,000USD | 29,780,000USD | 74,642,000USD | 31,720,000USD | 55,112,000USD | 1,470,000USD | -750,000USD | -744,000USD |
| Total Cash From Financing Activities | -12,724,000USD | 28,528,000USD | 126,528,000USD | 54,141,000USD | 51,470,000USD | 1,433,000USD | -1,006,000USD | 4,131,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 64,520,000USD | 22,655,000USD | 10,655,000USD | 0USD | 0USD | 642,000USD |
| Change In Cash | 25,680,000USD | -26,838,000USD | -22,185,000USD | 54,103,000USD | 37,866,000USD | -648,000USD | -1,889,000USD | 2,619,000USD |
| Begin Period Cash Flow | 47,247,000USD | 74,085,000USD | 96,270,000USD | 42,167,000USD | 4,301,000USD | 4,949,000USD | 6,838,000USD | 4,219,000USD |
| End Period Cash Flow | 72,927,000USD | 47,247,000USD | 74,085,000USD | 96,270,000USD | 42,167,000USD | 4,301,000USD | 4,949,000USD | 6,838,000USD |
| Other Cashflows From Investing Activities | -5,460,000USD | -37,079,000USD | -151,093,000USD | 854,000USD | -14,134,000USD | -119,000USD | 4,000USD | 4,000USD |
| Other Cashflows From Financing Activities | -25,035,999USD | -1,252,000USD | -12,634,000USD | -234,000USD | -19,189,000USD | -1,526,000USD | -282,000USD | 4,180,000USD |
| Unclassified Financing Cash Flow | -1,160,001USD | — | 77,533,000USD | 24,407,000USD | 26,674,000USD | 1,576,000USD | — | -4,053,000USD |
| Unclassified Investing Cash Flow | — | 75,753,000USD | 303,646,000USD | 6,919,000USD | 26,726,000USD | 1,113,000USD | 1,833,000USD | — |
| Sale Purchase Of Stock | — | — | -13,013,000USD | -876,000USD | -11,000,000USD | -29,000USD | 769,000USD | 4,875,000USD |
| Change To Liabilities | — | — | — | 2,775,000USD | 2,504,000USD | -4,457,000USD | 1,176,000USD | 3,439,000USD |
| Dividends Paid | — | — | — | -876,000USD | -127,000USD | -58,000USD | -127,000USD | -127,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 54,103,000USD | 37,866,000USD | -648,000USD | -1,889,000USD | 2,619,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | 14,524,000USD | — | -2,400,000USD | -22,467,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Segment | Branded | 30,704,000 | USD | 0001493152-26-022254 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Compounding | 13,499,000 | USD | 0001493152-26-022254 |
| FY 2025Yearly · 2025-12-31 | Segment | Branded | 195,756,000 | USD | 0001493152-26-008562 |
| FY 2025Yearly · 2025-12-31 | Segment | Imprimis Rx | 76,547,000 | USD | 0001493152-26-008562 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Branded | 51,582,000 | USD | 0001493152-25-021562 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Compounding | 20,056,000 | USD | 0001493152-25-021562 |
| Q3 2025Quarterly · 2025-09-30 | Product | Other Revenues | 141,000 | USD | 0001493152-25-021562 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product Sales Net | 71,497,000 | USD | 0001493152-25-021562 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Branded | 27,780,000 | USD | 0001493152-26-022254 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Compounding | 20,051,000 | USD | 0001493152-26-022254 |
| FY 2024Yearly · 2024-12-31 | Segment | Branded | 116,115,000 | USD | 0001493152-26-008562 |
| FY 2024Yearly · 2024-12-31 | Segment | Imprimis Rx | 83,499,000 | USD | 0001493152-26-008562 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Branded | 28,552,000 | USD | 0001493152-25-021562 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Compounding | 20,705,000 | USD | 0001493152-25-021562 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Revenues | 238,000 | USD | 0001493152-25-021562 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product Sales Net | 49,019,000 | USD | 0001493152-25-021562 |
| Q2 2024Quarterly · 2024-06-30 | Product | Other Revenues | 68,000 | USD | 0001493152-24-030575 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product Sales Net | 48,871,000 | USD | 0001493152-24-030575 |
| Q1 2024Quarterly · 2024-03-31 | Product | Other Revenues | 79,000 | USD | 0001493152-24-018902 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product Sales Net | 34,508,000 | USD | 0001493152-24-018902 |
| FY 2023Yearly · 2023-12-31 | Segment | Branded | 50,258,000 | USD | 0001493152-26-008562 |
| FY 2023Yearly · 2023-12-31 | Segment | Imprimis Rx | 79,935,000 | USD | 0001493152-26-008562 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Branded | 14,496,000 | USD | 0001493152-24-045295 |
| Q3 2023Quarterly · 2023-09-30 | Segment | Imprimis Rx | 19,769,000 | USD | 0001493152-24-045295 |
| Q2 2023Quarterly · 2023-06-30 | Product | Other Revenues | 3,928,000 | USD | 0001493152-24-030575 |
| Q2 2023Quarterly · 2023-06-30 | Product | Product Sales Net | 29,542,000 | USD | 0001493152-24-030575 |
| Q1 2023Quarterly · 2023-03-31 | Product | Other Revenues | 5,650,000 | USD | 0001493152-24-018902 |
| Q1 2023Quarterly · 2023-03-31 | Product | Product Sales Net | 20,453,000 | USD | 0001493152-24-018902 |
| Q4 2022Quarterly · 2022-12-31 | Product | Other Revenues — Commissions | 290,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Product | Other Revenues — Transfer Of Profit | 0 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Product | Product Sales Net | 20,091,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Product | Other Revenues — Commissions | 3,866,000 | USD | 0001493152-24-010518 |
| FY 2022Yearly · 2022-12-31 | Product | Other Revenues — Transfer Of Acquired Product Sales Profits | 1,205,000 | USD | 0001493152-24-010518 |
| FY 2022Yearly · 2022-12-31 | Product | Product Sales Net | 83,524,000 | USD | 0001493152-24-010518 |
| Q3 2022Quarterly · 2022-09-30 | Product | Other Revenues — Commissions | 1,044,000 | USD | 0001493152-23-040563 |
| Q3 2022Quarterly · 2022-09-30 | Product | Other Revenues — Transfer Of Acquired Product Profit | 204,000 | USD | 0001493152-23-040563 |
| Q3 2022Quarterly · 2022-09-30 | Product | Product Sales Net | 21,575,000 | USD | 0001493152-23-040563 |
| FY 2021Yearly · 2021-12-31 | Product | Other Revenues — Commissions | 3,253,000 | USD | 0001493152-23-008718 |
| FY 2021Yearly · 2021-12-31 | Product | Other Revenues — License | 20,000 | USD | 0001493152-23-008718 |
| FY 2021Yearly · 2021-12-31 | Product | Other Revenues — Transfer Of Profit | 99,000 | USD | 0001493152-23-008718 |
| FY 2021Yearly · 2021-12-31 | Product | Product Sales Net | 69,104,000 | USD | 0001493152-23-008718 |
| FY 2020Yearly · 2020-12-31 | Product | Commissions | 356,000 | USD | 0001493152-22-006525 |
| FY 2020Yearly · 2020-12-31 | Product | License | 36,000 | USD | 0001493152-22-006525 |
| FY 2020Yearly · 2020-12-31 | Product | Other Revenues | 392,000 | USD | 0001493152-22-006525 |
| FY 2020Yearly · 2020-12-31 | Product | Product Sales Net | 48,479,000 | USD | 0001493152-22-006525 |
| FY 2019Yearly · 2019-12-31 | Product | License | 28,000 | USD | 0001493152-21-005583 |
| FY 2019Yearly · 2019-12-31 | Product | Other Revenues | 28,000 | USD | 0001493152-21-005583 |
| FY 2019Yearly · 2019-12-31 | Product | Product Sales Net | 51,137,000 | USD | 0001493152-21-005583 |
| FY 2018Yearly · 2018-12-31 | Product | License Revenues | 38,000 | USD | 0001493152-20-003862 |
| FY 2018Yearly · 2018-12-31 | Product | Product Sales Net | 41,334,000 | USD | 0001493152-20-003862 |
| FY 2017Yearly · 2017-12-31 | Product | License Revenues | 90,000 | USD | 0001493152-19-003188 |
| FY 2017Yearly · 2017-12-31 | Product | Product Sales Net | 26,684,000 | USD | 0001493152-19-003188 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.